China Blood Products Industry Report, 2007-2008
  • Dec/2008
  • Hard Copy
  • USD $950 $665
  • Pages:30
  • Single User License
    (PDF Unprintable)       
  • USD $950 $665
  • Code: FA008
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $1,450 $1,015
  • Hard Copy + Single User License
  • USD $1,150 $805
      

China blood products industry is all along comparatively independent from global blood products industry. In the year of 1986, according to the rules from Ministry of Health, China prohibited the import of blood products except HAS. However, since 2002, HAS import had been also prohibited from BSE disease regions.

Considering the short supply of domestic blood products, in May 2008, State Council of China adjusted the import tariff of HSA products from 3% to zero during 1st Jun 2008 to the end of Dec 2008. However, due to the HAS price in China market lower than international market, foreign companies are seldom willing to export.

China has totally 33 blood products manufacturers. In the year of 2007, the blood products market scale in China was about CNY 6 billion. China has a great demand for albumin, due to the large number of liver disease patients; the other blood products also have a considerable demand in China such as gammaglobulin, immunoglobulin and plasma thromboplastin component.


Market Structure of China Blood Products, 2007

blood.jpg

Source: ResearchInChina

Based on the authoritative statistics from General Administration of China Customs, Pharmaceutical Industry Association and National Bureau of Statistics, this report is focused on the actuality of China blood products industry, as well as its development trend and investment opportunities and risks.

 

1. Overview of China Blood Products Industry
1.1 Market Overview
1.2 Key Manufacturers 

2. China Blood Plasma Market
2.1 Blood Plasma Stations
2.2 Blood Plasma Production
2.3 Blood Plasma Price

3. Development of Global Blood Products Industry
3.1 Development Courses
3.2 Status Quo

4. Key Blood Products
4.1 HSA
4.2 IVIG
4.3 HBIG
4.4 Rabies Immunoglobulin
4.5 Tetanus Immunoglobulin
4.6 PTC

5. Key Manufacturers in China 
5.1 Overview
5.2 Hualan Biological Engineering Co., Ltd
5.3 Shanghai RAAS Blood Products Co., Ltd
5.4 Shanghai Institute of Biological Products
5.5 Chengdu Rongsheng Pharmaceuticals Co., Ltd
5.6 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd
5.7 Guiyang Qianfeng Biological Product Liability Co., Ltd.

6. Investment Analysis 
6.1 Opportunities 
6.2 Risks
6.3 Suggestions
Market Structure of China Blood Products, 2007
Regional Sales of Top Six Blood Products Manufacturers in China, 2007
China Blood Products Industry Chain After the Reform of Blood Plasma Stations
Key Regulations of Blood Products in China
China Blood Plasma Productions, 2001-2007
China Blood Plasma Price and Forecast, 2005-2010
Blood Plasma Collection of Key Global Blood Products Manufacturers, 2007
Market Share Distribution of Global Key Blood Products Manufacturers, 2007
HAS Market Share Distribution of Hospitals in China, 2007
HAS Price Trend in China 
China and Global HAS Consumption Per Capital 
Sales Revenue of PTC in 16 Cities in China, 2001-2006
Major Products of Top Six Blood Products Manufacturers in China, 2007
Sales Revenue and Forecast of Hualan Biological Engineering Co., Ltd., 2007-2010
Profitability of Hualan Biological Engineering Co., Ltd &Shanghai RAAS Blood Products Co., Ltd
Major Products of Shanghai RAAS Blood Products Co., Ltd
Blood Plasma Collection and Production of Shanghai RAAS Blood Products Co., Ltd., 2005-2010
Sales Revenue and Forecast of Shanghai RAAS Blood Products Co., Ltd., 2005-2010
Fund-raising Investment Projects of of Shanghai RAAS Blood Products Co., Ltd., 2008
Blood Products of Shanghai Institute of Biological Products
Sales Network of Shanghai Institute of Biological Products, 2007
Sales Revenue, Net Profit and Forecast of Chengdu Rongsheng Pharmaceuticals Co., Ltd., 2008-2010 
Sales Revenue of Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., 2007
International Sales Network of Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., 2007
The Highest Retail Price of Partial Blood Products according to National Development and Reform Commission. 

Global and China DNA Sequencing Industry Research Report, 2014-2017

DNA sequencing is the process of reading nucleotide bases in a specific DNA molecule, that is to say determining the arrangement mode of adenine, thymine, cytosine, and guanine. It can be applied in a...

Global and China Stem Cell Industry Report, 2014-2017

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Stem cell therapy can be applied to treatmen...

China Human Vaccine Industry Report, 2014-2017

Vaccines can prevent and control infectious diseases, so the demand for these biological products is relatively rigid. In 2013, China’s human vaccine lot release volume grew by 4.9% from a year earlie...

China Blood Product Industry Report, 2014-2017

Plasma resource reserves and control are crucial to the development of blood products industry. Although the closure of 16 plasma collection stations in Guizhou in 2011 didn’t cause major disruption t...

China Animal Vaccine Industry Report, 2013-2016

Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. Europe and the United States and other developed countries are the main ...

China Contract Research Organization (CRO) Industry Report, 2013-2016

China CRO industry has developed rapidly in recent years, registering a CAGR of 27.2% during 2007-2013, of which the market size reached RMB 36 billion in 2013, occupying 10% of global market share. ...

Global and China Biodegradable Plastics Industry Report, 2013-2016

Global biodegradable plastic production and demand have grown rapidly in recent years, and the capacity reached 1-1.5 million t/a in 2012-2013. Among dozens of biodegradable plastic varieties develope...

Global and China Industrial Enzyme Industry Report, 2014-2016

In 2007-2013, the global industrial enzyme market size grew at the CAGR of 5.7%, reaching USD4.04 billion in 2013, 1.4 times that in 2007. The global industrial enzyme market is monopolized by a small...

China Heparin Industry Report, 2013-2015

Since the small intestines of pigs (raw materials for production of heparin) in China are abundant (the pig slaughtering volume in China approximates 50% of globe’s total) and heparin APIs are gradual...

China Lactic Acid and Derivative Industry Report, 2013

China’s lactic acid capacity and output continued to grow at the respective CAGR of 22.7% and 28.7% in 2007-2011. But limited by market demand, the annual output of most vendors was below their design...

China Human Vaccine Industry Report, 2012-2015

In the wake of China's economic growth and enhanced disease prevention awareness, Chinese human vaccine market has been expanding. In 2012, Chinese human vaccine market valued RMB10.5 billion with the...

China Blood Product Industry Report, 2012-2015

Plasma is a key raw material of the blood product industry. In August 2011, China shut down 16 plasma stations in Guizhou, resulting in a decrease of 15% in the plasma volume of the year. However, due...

China Animal Vaccine Industry Report, 2012-2015

In view of the frequent occurrence of animal epidemic diseases over the years, the Chinese government has increased investment in epidemic prevention and implemented compulsory immunization system. Be...

Global and China Monoclonal Antibody Industry Report, 2013

In recent years, the monoclonal antibody market around the globe has witnessed substantial growth, and the CAGR of market scale during 1997-2011 has reached 44% approximately. It is predicted that the...

China Insulin Industry Report, 2012-2015

China is a country with the largest number of diabetics. In 2011, the market scale of diabetes medicine in China approximated RMB13.8 billion, of which, insulin medicines mainly comprising recombinant...

China Heparin Industry Report, 2012-2014

China, abundant in heparin raw materials, has become one of the world’s largest heparin API producers and exporters, owning to the quality of heparin API having won international recognition gradually...

Global and China Industrial Enzyme Industry Report, 2012-2014

Industrial enzyme which refers to the enzyme preparation used for industrial purposes can be applied to detergent, animal feed, bread, brewing (beer, wine, etc.), papermaking, textile, bio-ethanol and...

China Blood Products Industry Report, 2011-2012

Blood plasma serves as key raw material in blood product industry. In August 2011, the shut-down of 16 plasma collection stations in Guizhou province, China resulted in a YoY decline of 15% in plasma ...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统